More than five million newborns. Over 5% skipped the shot in 2024. A 77% jump from 2017. Those numbers come from a sweeping analysis of electronic health records across hundreds of hospitals. They signal trouble.
The injection delivers vitamin K. It stops babies from bleeding inside their skulls or guts weeks after birth. Without it, the risk skyrockets. Infants face odds 81 times higher for late-onset vitamin K deficiency bleeding, according to the Centers for Disease Control and Prevention. One in five such cases ends in death. Survivors often carry brain damage that lasts a lifetime.
Rising Refusals Meet Silent Consequences
Hospitals once saw refusals in the low single digits. Now some report 10%, 15%, even 20%. St. Luke’s Health System in Idaho watched its rate climb from 3.8% in 2020 to 9.8% in 2025. One facility hit 20%. Mercy hospitals across four states logged 1,552 babies without the shot last year. That figure stood at 536 in 2021. The ProPublica investigation published May 6, 2026 lays out these shifts in stark detail, tying them to families declining the standard intramuscular dose given in the thigh soon after delivery.
Doctors describe frantic conversations in delivery rooms. Parents arrive armed with online theories. Some worry the shot contains toxins. Others believe breast milk suffices or that delayed cord clamping transfers enough vitamin K. Research shows neither holds. And a few cite long-debunked claims linking the shot to leukemia. Pediatric hematologist Dr. Robert Sidonio Jr. at Children’s Healthcare of Atlanta put it plainly. “If you don’t track it, you don’t document it.” He called for VKDB to become a reportable condition, like measles cases.
The national study, published in JAMA in December 2025 and led by Dr. Kristan Scott, neonatologist at Children’s Hospital of Philadelphia, examined records from more than 5 million births. The share of infants not receiving vitamin K rose from 2.92% in 2017 to 5.18% in 2024. Scott noted the absence of centralized tracking. “We don’t have a clean data repository provided by public health systems or the state that would allow us to be able to track this in a more systematic fashion.”
But the human cost surfaces in emergency rooms and morgues. A 7-week-old in Maryland seized and died. An 11-pound girl in Alabama stopped breathing in 20-second bursts. In Kentucky a baby vomited, turned lethargic, and never recovered. The ProPublica report recounts five families who lost infants to unexplained brain bleeds. One mother wrote, “No one could’ve prepared us for the heartbreak we faced 6 weeks after our little miracle was born. She had a spontaneous unexplained brain bleed that led to brain death.” A father, initially resistant to all vaccines, later reflected, “I can sit here and be upset and sad, but this brought me closer to God. I just can’t wait to be with him.”
Neonatologists say the condition hides. Early VKDB hits in the first week. Late-onset strikes between two and 12 weeks, often in exclusively breastfed babies whose milk carries little vitamin K. Newborns produce almost none on their own. The placenta transfers scant amounts. Symptoms arrive without warning. Bruising. Bleeding from the umbilical stump. Then sudden intracranial hemorrhage. Blood pools. Oxygen fails to reach tissue. The damage mimics strokes in miniature adults.
Dr. Ivan Hand, director of neonatology at Kings County Hospital Center in New York and co-author of American Academy of Pediatrics policy, sees the paradox. “We’re a victim of our own success. Since we’ve been treating babies with vitamin K, we haven’t seen much deficiency bleeding, so people think it doesn’t exist.” Routine use since the 1960s slashed cases dramatically. Before that, hospitals managed clusters of tragic bleeds. Now those clusters reappear in pockets where refusal runs high.
Dr. Timmy Ho, a neonatologist with a decade in practice, once fielded one or two refusals weekly. Lately he sees three or four parents a day decline. In a New York Times report from February 2026, he described the shift. “It comes from good intentions. It’s people who are scared of doing something wrong to their child. The trouble is, by not doing something, you are doing something wrong to your child.” His colleague Dr. Cliff O’Callahan watched his success rate in persuading hesitant parents drop from 75% to under 50%.
Refusals cluster with other choices. Parents who say no to vitamin K often decline the hepatitis B vaccine at birth and erythromycin eye ointment that prevents blindness from maternal infection. A March 2026 CNN analysis connected the pattern to broader hesitancy amplified after the pandemic. Dr. Tom Patterson, a pediatrician in Idaho, once saw half the newborns on his shift miss the shot. On another day more than a quarter went without. He now pleads directly with families.
Social media accelerates the trend. Algorithms surface content questioning routine newborn care. Podcaster Candace Owens in 2023 suggested the shot implies babies are designed incorrectly. Misinformation about preservatives like benzyl alcohol persists despite evidence the tiny amount causes no harm. Some seek oral alternatives sold online. Those require multiple doses over weeks and lack FDA approval for this use. The intramuscular shot works in one dose. It has for decades.
Yet some parents remain unmoved. Dr. Jaspreet Loyal, pediatric hospitalist at Yale Medicine, observed that scarce public data creates false comfort. “A lot of the providers don’t have this on their radar. The lack of data is almost acting like a reassurance for families that this risk is worth taking.” Dr. Allison Henry at Cedars-Sinai in Los Angeles recalled when education seemed unnecessary. “This was not something we even bothered to spend much educational effort on because there was this simple, safe intervention.”
Rep. Kim Schrier, a physician and Democratic congresswoman from Washington, connects the dots to eroding trust. “You don’t say anything about it, but the doubt you’ve created about all of medicine and science is causing parents to make dangerous decisions.” The trend coincides with policy debates at the federal level. HHS Secretary Robert F. Kennedy Jr. has questioned certain vaccine schedules. A federal judge recently blocked revisions. Public health officials still affirm the shot as standard. An HHS spokesperson told ProPublica, “Vitamin K at birth remains the standard of care.”
Dr. Anna Morad at Vanderbilt’s Monroe Carell Jr. Children’s Hospital remembers a 2013 cluster in Nashville. Four infants, ages 6 to 15 weeks, arrived with bleeding. All had refused vitamin K. One survived with developmental delays. She once thought education had solved the issue. “I’ll be honest, I thought we had turned the corner. Naively, I thought that would be enough.” Now she picks the shot without hesitation. “I’m picking vitamin K every day. Absolutely.”
The gap in surveillance worries specialists. Death certificates sometimes list intracranial hemorrhage without tying it to vitamin K status. Prematurity or liver issues complicate attribution. Yet specialists estimate hundreds of additional brain bleeds occur yearly as refusals grow. In 2024 more than 700 newborns died from spontaneous brain bleeding. A portion traces to this deficiency. The National Institutes of Health summary from January 2026 underscored the 77% rise and warned of perceptions that the shot is unnecessary. Dr. Scott warned, “Unfortunately, opting out of vitamin K for a newborn is akin to gambling with a child’s health, forgoing a straightforward and safe measure that effectively prevents severe complications.”
Some families change course after tragedy. Two interviewed by ProPublica accepted the shot for later children. Others double down, posting online that hospitals push interventions for profit. One grieving father initially blamed providers for lost vaccine revenue. Reality eventually shifted his view toward faith.
Pediatricians now spend more time counseling. They explain the Nobel Prize-winning discovery of vitamin K in the 1940s. They describe how the shot eliminated a once-common threat. They counter claims with data. Still, persuasion rates fall. And in intensive care units, nurses like Karen Skific note refusals that “used to be never” now hover around 5% even in high-risk settings.
The pattern fits larger currents of skepticism. Vaccine hesitancy spills into non-vaccine care. Parents seek control in an information-saturated environment. But the newborn’s biology offers no debate. Vitamin K levels start low. They stay low without intervention. Bleeding, when it starts late, gives little warning. Treatment then becomes rescue. Plasma, repeated vitamin K doses, neurosurgery. Outcomes vary. Some infants stabilize. Others do not.
Public health lacks a national VKDB registry. That absence limits precise counting of deaths or injuries. Doctors call for better reporting. Hospitals experiment with scripts and videos. A few systems flag refusals as high-risk safety events, per recent Pediatrics perspectives. Yet the core issue remains trust. Restore it, and refusals may ease. Fail, and more infants face unnecessary risk.
One fact stands out. The shot costs little. It takes seconds. Its benefit endures months. Babies who receive it almost never develop this bleeding disorder. Those who don’t carry the gamble. As rates edge higher in scattered hospitals and certain demographics, particularly among non-Hispanic white families, the cumulative effect grows. Preventable cases. Preventable grief. A simple measure stands between them and safety. Whether enough parents hear that message will shape the next set of numbers.
WebProNews is an iEntry Publication